- Home
- CIVB vs KMDA Comparison
CIVB vs KMDA Comparison
Compare CIVB & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIVB
- KMDA
- Stock Information
- Founded
- CIVB 1884
- KMDA 1990
- Country
- CIVB United States
- KMDA Israel
- Employees
- CIVB N/A
- KMDA N/A
- Industry
- CIVB Major Banks
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- CIVB Finance
- KMDA Health Care
- Exchange
- CIVB Nasdaq
- KMDA Nasdaq
- Market Cap
- CIVB 402.3M
- KMDA 398.5M
- IPO Year
- CIVB N/A
- KMDA N/A
- Fundamental
- Price
- CIVB $22.19
- KMDA $6.88
- Analyst Decision
- CIVB Buy
- KMDA Strong Buy
- Analyst Count
- CIVB 5
- KMDA 2
- Target Price
- CIVB $25.25
- KMDA $13.00
- AVG Volume (30 Days)
- CIVB 117.7K
- KMDA 79.3K
- Earning Date
- CIVB 10-23-2025
- KMDA 11-12-2025
- Dividend Yield
- CIVB 3.07%
- KMDA 2.91%
- EPS Growth
- CIVB 33.82
- KMDA 27.97
- EPS
- CIVB 2.66
- KMDA 0.32
- Revenue
- CIVB $163,095,000.00
- KMDA $169,517,000.00
- Revenue This Year
- CIVB $17.30
- KMDA $14.49
- Revenue Next Year
- CIVB $12.90
- KMDA $10.12
- P/E Ratio
- CIVB $8.33
- KMDA $20.92
- Revenue Growth
- CIVB 11.59
- KMDA 9.67
- 52 Week Low
- CIVB $17.47
- KMDA $5.23
- 52 Week High
- CIVB $25.59
- KMDA $9.16
- Technical
- Relative Strength Index (RSI)
- CIVB 64.13
- KMDA 50.23
- Support Level
- CIVB $19.84
- KMDA $6.72
- Resistance Level
- CIVB $21.64
- KMDA $7.18
- Average True Range (ATR)
- CIVB 0.72
- KMDA 0.20
- MACD
- CIVB 0.15
- KMDA 0.02
- Stochastic Oscillator
- CIVB 90.38
- KMDA 54.41
About CIVB Civista Bancshares Inc.
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agriculture, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. Majority of its revenues are derived from the interest and fees gained on loans.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.